Skip to Content

Fechas de fin de año: Facturación de pedidos para envío en Ciudad de México, zona Metropolitana del Valle de México y Toluca hasta 13/12. Para otras regiones, hasta el 11/12. Receso de Merck Mexico del 18/12 al 02/01.

Merck
  • A Self-Delivery Chimeric Peptide for Photodynamic Therapy Amplified Immunotherapy.

A Self-Delivery Chimeric Peptide for Photodynamic Therapy Amplified Immunotherapy.

Macromolecular bioscience (2018-12-24)
Hong Cheng, Gui-Ling Fan, Jing-Hao Fan, Rong-Rong Zheng, Lin-Ping Zhao, Ping Yuan, Xiao-Ya Zhao, Xi-Yong Yu, Shi-Ying Li
ABSTRACT

In this paper, a self-delivery chimeric peptide PpIX-PEG8 -KVPRNQDWL is designed for photodynamic therapy (PDT) amplified immunotherapy against malignant melanoma. After self-assembly into nanoparticles (designated as PPMA), this self-delivery system shows high drug loading rate, good dispersion, and stability as well as an excellent capability in producing reactive oxygen species (ROS). After cellular uptake, the ROS generated under light irradiation could induce the apoptosis and/or necrosis of tumor cells, which would subsequently stimulate the anti-tumor immune response. On the other hand, the melanoma specific antigen (KVPRNQDWL) peptide could also activate the specific cytotoxic T cells for anti-tumor immunity. Compared to immunotherapy alone, the combined photodynamic immunotherapy exhibits significantly enhanced inhibition of melanoma growth. Both in vitro and in vivo investigations confirm that PDT of PPMA has a positive effect on anti-tumor immune response. This self-delivery system demonstrates a great potential of this PDT amplified immunotherapy strategy for advanced or metastatic tumor treatment.